Skip to content

Study · Not a test of the peptide alone · 2019

1 result

Chivosazole A Modulates Protein-Protein Interactions of Actin.

Wang S, Gegenfurtner FA, Crevenna AH, Ziegenhain C, Kliesmete Z, Enard W, Müller R, Vollmar AM, Schneider S, Zahler S

Journal of natural products1 Jul 2019Cited by 10 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Mechanism

    Chivosazole A bound to actin inhibited the interaction of G-actin with thymosin-β4, together with gelsolin, profilin and cofilin.

    In plain wordsIn lab tests, the compound chivosazole A blocked actin from binding thymosin-β4. The study tested the compound, not thymosin-β4 as a treatment.

    Outcome
    DecreaseInteraction of G-actin with thymosin-β4 in the presence of chivosazole A
    Study

    n: not reported in source

    Actin with chivosazole A (crystal structure and binding assays)
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    interaction with gelsolin, profilin, cofilin, and thymosin-β4 is inhibited.
    1 context sentence
    Summary · context
    We provide a crystal structure of the natural product chivosazole A (ChivoA) bound to actin and show that-in addition to inhibiting nucleation, polymerization, and severing of F-actin filaments-it selectively modulates binding of ABPs to G-actin: Although unphysiological actin dimers are induced by…

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.